A single, double lumen high-flow catheter for patients undergoing peripheral blood stem cell transplantation. Experience at the National Cancer Institute in Mexico

[1]  J. Perkins,et al.  Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  E. Shpall,et al.  High-dose therapy with autologous bone marrow transplantation for the treatment of solid tumors. , 1994, Current opinion in oncology.

[3]  R. Meagher,et al.  Techniques of harvesting and cryopreservation of stem cells. , 1993, Hematology/oncology clinics of North America.

[4]  J. Armitage,et al.  The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. , 1991, Blood.

[5]  E. Bour,et al.  Experience with the double lumen Silastic catheter for hemoaccess. , 1990, Surgery, gynecology & obstetrics.

[6]  J. Wesley,et al.  Total parenteral nutrition catheter sepsis: impact of the team approach. , 1986, JPEN. Journal of parenteral and enteral nutrition.

[7]  D. Maki,et al.  A semiquantitative culture method for identifying intravenous-catheter-related infection. , 1977, The New England journal of medicine.

[8]  D. Maki,et al.  Infection control in intravenous therapy. , 1973, Annals of internal medicine.